Ifosfamide (Intravenous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Ifosfamide (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Ifex

Description

Ifosfamide belongs to the group of medicines called alkylating agents. Ifosfamide injection is used in combination with other medicines to treat cancer of the testicles.

Ifosfamide interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by ifosfamide, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.

Before you begin treatment with ifosfamide, you and your doctor should talk about the benefits this medicine will do as well as the risks of using it.

This medicine is to be administered only by or under the immediate supervision of your doctor.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, ifosfamide is used in certain patients with the following medical conditions:

  • Acute lymphocytic leukemia (a type of cancer of the blood).
  • Cancer of the bladder.
  • Cancer of the bone (including Ewing's sarcoma).
  • Cancer of the breast.
  • Cancer of the cervix.
  • Cancer of the endometrium.
  • Cancers of the head and neck.
  • Cancer of the lungs.
  • Cancer of the ovaries.
  • Lymphomas.
  • Neuroblastoma (a certain type of brain cancer).
  • Thymoma and other cancer of the thymus (a small organ beneath the breastbone).
  • Tumors in the ovaries.
  • Wilms' tumor (a cancer of the kidneys occurring mainly in children).

This product is available in the following dosage forms:

  • Solution
  • Powder for Solution
Before Using
DR600773 Portions of this document last updated: May 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger